The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways

- Zhao, Menglin, Wang, Yanyan, Zhang, Zining, Tang, Mingyue, Li, Huiyuan, Wang, Zishu, Jiang, Chenchen, Su, Fang, Zhang, Yue, Li, Xinwei, Mi, Jiaqi, Wang, Qiang, Geng, Zhijun, Zuo, Lugen, Song, Xue, Ge, Sitang

Treatment outcomes of advanced hepatocellular carcinoma in real-life practice: Chemotherapy versus multikinase inhibitors

- Oranratnachai, Songporn, Rattanasiri, Sasivimol, Sirachainan, Ekaphop, Tansawet, Amarit, Raunroadroong, Nilubol, McKay, Gareth J., Attia, John, Thakkinstian, Ammarin

Efficacy of first line systemic chemotherapy and multikinase inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis

- Oranratnachai, Songporn, Rattanasiri, Sasivimol, Pooprasert, Anantaporn, Tansawet, Amarit, Reungwetwattana, Thanyanan, Attia, John, Thakkinstian, Ammarin

Roadmap to resuming care for liver diseases after coronavirus disease-2019

- Kapuria, Devika, Bollipo, Steven, Rabiee, Atoosa, Ben-Yakov, Gil, Kumar, Goutham, Siau, Keith, Lee, Hye-Won, Congly, Stephen, Turnes, Juan, Dhanasekaran, Renumathy, Lui, Rashid N.

17-demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells

- Zhao, Surong, Li, Hongmei, Jiang, Chenchen, Ma, Tao, Wu, Chengzhu, Huo, Qiang, Liu, Hao

Epidemiology

- Leong, Trishe Y.-M., Leong, Anthony S.-Y.

How to treat: non-alcoholic fatty liver disease

- Teoh, Wun-Chung, Batey, Robert G.

Pathology

- Leong, Anthony S.-Y., Leong, Trishe Y.-M., Wannakrairot, Pongsak

Epidemiology and carcinogenesis of hepatocellular carcinoma

- Leong, Trishe Y.-M., Leong, Anthony S.-Y.